News Related to Anakinra

Related coverage linked through entity extraction aliases.

CAR-T toxicity management shifts toward phenotype- and mechanism-based intervention

Apr 24, 2026

CAR-T toxicity management is shifting toward phenotype- and mechanism-based intervention. Key issues include CRS, ICANS, IEC-HS, and long-term risks of cytopenia and infection.

Neurogene's NGN-401 Receives FDA Breakthrough Designation for Rett Syndrome

Mar 05, 2026

The FDA granted Breakthrough Therapy designation to NGN-401, Neurogene's gene therapy for Rett syndrome, based on interim data showing durable functional improvements. The company expects to complete pivotal trial dosing in Q2 2026.